Effectiveness of the HPV vaccine in women with HIV and its impact on cervical cancer screening
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies
This study is looking at how well the HPV vaccine works for women with HIV and how it affects their cervical cancer screenings, aiming to find better ways to keep them healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11080910 on NIH RePORTER |
What this research studies
This research investigates how effective the HPV vaccine is for women living with HIV, particularly focusing on its real-world impact on cervical cancer screening accuracy. The study aims to evaluate the effectiveness of the vaccine and explore new screening methods that could improve outcomes for these women. By collaborating with the Pediatric HIV/AIDS Cohort Study, the research will analyze data to understand the relationship between vaccination and cervical cancer screening results. This approach seeks to address the unique challenges faced by women living with HIV in terms of cervical cancer risk and screening.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV, particularly those who are young or have been vaccinated against HPV.
Not a fit: Patients who are not living with HIV or who have not received the HPV vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cervical cancer prevention strategies for women living with HIV.
How similar studies have performed: Previous studies have shown promise in improving cervical cancer screening methods for women living with HIV, indicating that this research builds on existing knowledge.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Moscicki, Anna-Barbara — University of California Los Angeles
- Study coordinator: Moscicki, Anna-Barbara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.